EUVIMEDEUVIMED entdecken
Crossref

Hepatitis B surface antigen seroclearance after nucleos(t) ide analogue discontinuation in non-cirrhotic patients with chronic hepatitis B

Zeynep Melekoglu Ellik, Fatma Tugce Sah, Ozge Koc, Esra Tunc, Volkan Yilmaz, Emin Bodakci, Mesut Gumussoy, Mubin Ozercan, Ramazan Erdem Er, Saba Kiremitci, Atilla Halil Elhan, Berna Savas und 3 weitere

Hepatology Forum · 2026 · 7 (4) · 337-344

DOI: 10.14744/hf.2026.12274 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Hepatology Forum, 2026. Verfasst von Zeynep Melekoglu Ellik und 14 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Aim: This study aimed to evaluate the clinical outcomes following the discontinuation of nucleos(t)ide analogue (NA) treatment in hepatitis B e antigen (HBeAg)-negative patients with chronic hepatitis B (CHB). Materials and Methods: This single-center retrospective cohort study included 146 non-cirrhotic patients with CHB who achieved long-term viral suppression under NA treatment. Seventy-three patients discontinued NA treatment, while a historical age- and sex-matched control group consisted of 73 patients who continued NA treatment. Results: Hepatitis B surface antigen (HBsAg) seroclearance occurred in eight patients (11%) in the treatment-discontinuation group, while none was observed in the treatment-contin-ued group (p = 0.004). The cumulative probability of HBsAg loss was 16.9% at month 120 after NA discontinuation. Firth-penalized Cox regression analysis identified younger age (

Zitieren

APA

Ellik, Z. M., Sah, F. T., Koc, O., Tunc, E., Yilmaz, V., Bodakci, E., Gumussoy, M., Ozercan, M., Er, R. E., Kiremitci, S., Elhan, A. H., Savas, B., Gokcan, H., Yurdaydin, C., & Idilman, R. (2026). Hepatitis B surface antigen seroclearance after nucleos(t) ide analogue discontinuation in non-cirrhotic patients with chronic hepatitis B. Hepatology Forum, 7(4), 337-344. https://doi.org/10.14744/hf.2026.12274

Vancouver

Ellik ZM, Sah FT, Koc O, Tunc E, Yilmaz V, Bodakci E, et al. Hepatitis B surface antigen seroclearance after nucleos(t) ide analogue discontinuation in non-cirrhotic patients with chronic hepatitis B. Hepatology Forum. 2026;7(4):337-344. doi:10.14744/hf.2026.12274

BibTeX
@article{Ellik2026,
  author = {Ellik, Zeynep Melekoglu and Sah, Fatma Tugce and Koc, Ozge and Tunc, Esra and Yilmaz, Volkan and Bodakci, Emin and Gumussoy, Mesut and Ozercan, Mubin and Er, Ramazan Erdem and Kiremitci, Saba and Elhan, Atilla Halil and Savas, Berna and Gokcan, Hale and Yurdaydin, Cihan and Idilman, Ramazan},
  title = {Hepatitis B surface antigen seroclearance after nucleos(t) ide analogue discontinuation in non-cirrhotic patients with chronic hepatitis B},
  journal = {Hepatology Forum},
  year = {2026},
  volume = {7},
  number = {4},
  pages = {337--344},
  doi = {10.14744/hf.2026.12274}
}
Kostenlos starten →